Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DLBCL Activated B-Cell Type”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Testing effectiveness (Phase 2)Study completedNCT01325701
What this trial is testing

Safety and Efficacy Study of a BTK Inhibitor in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large Cell B-lymphoma
Pharmacyclics LLC. 78
Testing effectiveness (Phase 2)Active Not RecruitingNCT03731234
What this trial is testing

Ibrutinib + R-CHOP Followed by Ibrutinib Maintenance

Who this might be right for
DLBCL
Fondazione Italiana Linfomi - ETS 75
Early research (Phase 1)Study completedNCT03742258
What this trial is testing

Combination Chemotherapy and TAK-659 as Front-Line Treatment in Treating Patients With High-Risk Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma Activated B-Cell TypeDiffuse Large B-Cell Lymphoma Germinal Center B-Cell Type+4 more
Northwestern University 12
Early research (Phase 1)Study completedNCT01705847
What this trial is testing

A Phase 1b Study Evaluating GS-9820 in Subjects With Lymphoid Malignancies

Who this might be right for
Lymphoid Malignancies
Gilead Sciences 39
Early research (Phase 1)Looking for participantsNCT06667687
What this trial is testing

Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
AbbVie 165
Testing effectiveness (Phase 2)WithdrawnNCT01415765
What this trial is testing

MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma

Who this might be right for
Lymphoma, Diffuse Large-Cell B-cellDiffuse, Large B-cell LymphomaLymphoma, Diffuse Large-Cell+1 more
National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT05107674
What this trial is testing

NX-1607 in Adults With Advanced Malignancies

Who this might be right for
Ovarian Cancer, EpithelialGastric CancerGastroEsophageal Junction (GEJ) Cancer+11 more
Nurix Therapeutics, Inc. 345
Early research (Phase 1)Study completedNCT02112526
What this trial is testing

Acalabrutinib (ACP-196), a Btk Inhibitor, for Treatment of de Novo Activated B-cell (ABC) Subtype of Diffuse Large B-Cell Lymphoma

Who this might be right for
Activated B-cell Diffuse Large B-Cell Lymphoma (ABC DLBCL)
Acerta Pharma BV 21
Very early researchLooking for participantsNCT04512716
What this trial is testing

Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

Who this might be right for
B-ALLDLBCLB ALL+8 more
Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Looking for participantsNCT04920617
What this trial is testing

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Relapsed Diffuse Large B-cell LymphomaRefractory Diffuse Large B-cell Lymphoma
ImmunoVaccine Technologies, Inc. (IMV Inc.) 102
Testing effectiveness (Phase 2)Study completedNCT01148108
What this trial is testing

Study of Canfosfamide in Refractory or Relapsed Mantle Cell, Diffuse Large B Cell Lymphoma and Multiple Myeloma

Who this might be right for
Mantle Cell LymphomaB Cell LymphomaMultiple Myeloma
Telik 14
Early research (Phase 1)Ended earlyNCT05144347
What this trial is testing

Study of XL114 in Subjects With Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)Activated B-Cell Type Diffuse Large B-Cell Lymphoma (ABC-DLBCL)Mantle Cell Lymphoma (MCL)+2 more
Exelixis 2
Large-scale testing (Phase 3)Study completedNCT02285062
What this trial is testing

Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Celgene 570